共 182 条
[1]
Magnussen C(2017)Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: results from the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe) Circulation 136 1588-1597
[2]
Niiranen TJ(2018)Atrial fibrillation manifestations risk factors and sex differences in a population-based cohort (from the Gutenberg Health Study) Am J Cardiol 122 76-82
[3]
Ojeda FM(2016)Hormone replacement therapy and risk of atrial fibrillation in Taiwanese menopause women: a nationwide cohort study Sci Rep 6 24132-23
[4]
Gianfagna F(2010)A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury Am J Physiol Heart Circ Physiol 298 H16-78
[5]
Blankenberg S(2010)Estrogen receptor activation and cardioprotection in ischemia reperfusion injury Trends Cardiovasc Med 20 73-230
[6]
Njolstad I(2003)Sources of estrogen and their importance J Steroid Biochem Mol Biol 86 225-148
[7]
Magnussen C(2015)Activation of GPR30 inhibits cardiac fibroblast proliferation Mol Cell Biochem 405 135-824
[8]
Ojeda FM(2020)Atrial fibrosis underlying atrial fibrillation (review) Int J Mol Med 47 9-1738
[9]
Wild PS(2013)Angiotensin receptor blockers and statins could alleviate atrial fibrosis via regulating platelet-derived growth factor/Rac1/nuclear factor-Kappa B axis Int J Med Sci 10 812-47
[10]
Sorensen N(2018)Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology Physiol Rev 98 1627-2793